Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Y Dodd

Transfusion

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Transfusion|April 12, 2005
Human herpesvirus-8: what (not) to do?Roger Y Dodd
Transfusion|June 16, 2010
Prions and precautions: be careful for what you askRoger Y Dodd
Transfusion|April 24, 2004
Bovine spongiform encephalopathy, variant CJD, and blood transfusion: beefer madness?Roger Y Dodd
Transfusion|July 22, 2014
Getting to know the unknownRoger Y Dodd
Transfusion|September 8, 2011
B19: benign or not?Roger Y Dodd
Transfusion|January 19, 2017
Epidemiology, performance characteristics, or both?Roger Y Dodd
Transfusion|March 7, 2019
Concerning the efficacy of pathogen inactivationRoger Y Dodd
Transfusion|July 13, 2013
Infectivity of occult hepatitis B from two different points of viewCelso Bianco, Roger Y Dodd
Transfusion|June 16, 2010
Human herpesvirus-8: what (not) to do redux?Louis M Katz, Roger Y Dodd
Transfusion|January 8, 2019
Technical solutions to social issues?Roger Y Dodd, Susan L Stramer
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Transfusion|April 12, 2005
Human herpesvirus-8: what (not) to do?Roger Y Dodd
Transfusion|June 16, 2010
Prions and precautions: be careful for what you askRoger Y Dodd
Transfusion|April 24, 2004
Bovine spongiform encephalopathy, variant CJD, and blood transfusion: beefer madness?Roger Y Dodd
Transfusion|July 22, 2014
Getting to know the unknownRoger Y Dodd
Transfusion|September 8, 2011
B19: benign or not?Roger Y Dodd
Transfusion|January 19, 2017
Epidemiology, performance characteristics, or both?Roger Y Dodd
Transfusion|March 7, 2019
Concerning the efficacy of pathogen inactivationRoger Y Dodd
Transfusion|July 13, 2013
Infectivity of occult hepatitis B from two different points of viewCelso Bianco, Roger Y Dodd
Transfusion|June 16, 2010
Human herpesvirus-8: what (not) to do redux?Louis M Katz, Roger Y Dodd
Transfusion|January 8, 2019
Technical solutions to social issues?Roger Y Dodd, Susan L Stramer
Pageof 9